missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Rat GM-CSF Recombinant Protein

E. coli Recombinant Protein

1678.00 NOK - 25130.00 NOK

Specifications

Accession Number P48750
Concentration 200 μg/mL
For Use With (Application) Control, ELISA, Western Blot
Formulation PBS with no preservative; pH 7.2
Gene ID (Entrez) 116630
View More Specs

Products 4
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17606715
View Documents
Invitrogen™
RP87916
10 μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A
17616715
View Documents
Invitrogen™
RP87917
25 μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A
17626715
View Documents
Invitrogen™
RP87918
100 μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A
17636715
View Documents
Invitrogen™
RP87919
500 μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A
Description

Description

GM-CSF (Granulocyte-Macrophage colony-stimulating factor) is a 14.6kDa hematopoietic growth factor that exists in glycosylated and non-glycosylated biologically active forms, and stimulates the development of granulocytes, macrophages, early megakaryocytes and eosinophil progenitor cells. The active form of the GM-CSF protein is found extracellularly as a homodimer and the GM-CSF gene has been localized to a cluster of related genes at chromosome region 5q31, which is known to be associated with interstitial deletions in the 5q-syndrome and acute myelogenous leukemia. Other genes in the cluster include those encoding interleukins 4, 5, and 13. The ability of recombinant GM-CSF to increase hematopoietic cell recovery has become a focus area in the therapeutic treatment of patients following bone marrow transplantation. Recent studies have investigated GM-CSF in inflammatory and autoimmune diseases such as arthritis, arthritis related interstitial lung disease, nephritis, and psoriasis. In the CNS, GM-CSF depletion or neutralization has been studied in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).
Specifications

Specifications

P48750
Control, ELISA, Western Blot
116630
Rat GM-CSF (aa 18-144)
-20°C
0.01 ng/ μg cytokine
CSF2
Unconjugated
Liquid
200 μg/mL
PBS with no preservative; pH 7.2
14.6 kD
E. coli
RUO
colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; Molgramostin; put. GM-CSF; sargramostim
Rat
Recombinant
>95%
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.